Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin Lymphoma

NCT05621096 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT05621096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin Lymphoma
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 21, 2023
Completion date
September 30, 2027
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dlbcl - diffuse large b cell lymphoma, follicular lymphoma, high-grade b-cell lymphoma, indolent b-cell non-hodgkin lymphoma, mediastinal large b-cell lymphoma, refractory non-hodgkin lymphoma, relapsed non-hodgkin lymphoma